Pharmaforce ApS: Financial statements 2018
CVR: 26394198
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Pharmaforce ApS (CVR 26394198) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 3,684,787 and a net result of DKK 1,177,199 compared with DKK 825,691 the year before. That is an increase of 62.8% compared with the year before. Equity in the 2018 report amounted to DKK 2,163,545. The solvency ratio was 44.5%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 3,684,787
- Profit/Loss
- DKK 1,177,199
- Equity
- DKK 2,163,545
- Total Assets
- DKK 4,866,144
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 3.7 mio. | 1.2 mio. | 2.2 mio. | 3 |
| 2017 | - | 2.3 mio. | 826 t. | 986 t. | 2 |
| 2016 | - | 1.1 mio. | -74 t. | 161 t. | 2 |
| 2015 | - | 312 t. | 149 t. | 234 t. | - |
| 2014 | - | 1.2 mio. | 896 t. | 85 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Pharmaforce ApS has published its annual report for 2017. Gross profit came to DKK 2,263,716, and the net result was DKK 825,691.
About Pharmaforce ApS
Pharmaforce ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Mads Louie Frazier. The company is owned by Pfam Holding ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. Equity in the 2025 report amounted to DKK 4,328,882.